MedPath
HSA Approval

MOXILEN 250 CAPSULE 250 mg

SIN00964P

MOXILEN 250 CAPSULE 250 mg

MOXILEN 250 CAPSULE 250 mg

May 10, 1988

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01CA04

amoxicillin

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

Medochemie Ltd (Factory B)

Active Ingredients

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

250 mg

Amoxicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXILEN 250 CAPSULE 250 mg - HSA Approval | MedPath